These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 24284465

  • 1. Meaningful improvement in walking performance after Botulinum neurotoxin A (BoNT-A) in chronic spastic patients.
    Cioncoloni D, Taddei S, Bielli S, Annunziata P, Mazzocchio R.
    NeuroRehabilitation; 2014; 34(1):185-92. PubMed ID: 24284465
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Functional outcomes following ultrasound-guided botulinum toxin type A injections to reduce spastic equinovarus in adult post-stroke patients.
    Aktürk S, Büyükavcı R, Ersoy Y.
    Toxicon; 2018 May; 146():95-98. PubMed ID: 29530514
    [Abstract] [Full Text] [Related]

  • 4. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
    Hameau S, Bensmail D, Robertson J, Boudarham J, Roche N, Zory R.
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):515-23. PubMed ID: 24651151
    [Abstract] [Full Text] [Related]

  • 5. Botulinum Toxin Type A Treatment Combined with Intensive Rehabilitation for Gait Poststroke: A Preliminary Study.
    Uchiyama Y, Koyama T, Wada Y, Katsutani M, Kodama N, Domen K.
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1975-1986. PubMed ID: 29610039
    [Abstract] [Full Text] [Related]

  • 6. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients.
    Carda S, Invernizzi M, Baricich A, Cisari C.
    Clin Rehabil; 2011 Dec; 25(12):1119-27. PubMed ID: 21729974
    [Abstract] [Full Text] [Related]

  • 7. Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial.
    Cinone N, Letizia S, Santoro L, Facciorusso S, Armiento R, Picelli A, Ranieri M, Santamato A.
    Toxins (Basel); 2019 Apr 08; 11(4):. PubMed ID: 30965599
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait.
    Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune TM.
    Stroke; 2008 Oct 08; 39(10):2803-8. PubMed ID: 18635841
    [Abstract] [Full Text] [Related]

  • 10. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.
    Disabil Rehabil; 2013 Apr 08; 35(7):596-605. PubMed ID: 22928803
    [Abstract] [Full Text] [Related]

  • 11. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
    Santamato A, Cinone N, Panza F, Letizia S, Santoro L, Lozupone M, Daniele A, Picelli A, Baricich A, Intiso D, Ranieri M.
    Drugs; 2019 Feb 08; 79(2):143-160. PubMed ID: 30623347
    [Abstract] [Full Text] [Related]

  • 12. Effects of botulinum neurotoxin on spatio-temporal gait parameters of patients with chronic stroke: a prospective open-label study.
    Gastaldi L, Lisco G, Pastorelli S, Dimanico U.
    Eur J Phys Rehabil Med; 2015 Oct 08; 51(5):609-18. PubMed ID: 25519765
    [Abstract] [Full Text] [Related]

  • 13. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study.
    Baricich A, Picelli A, Carda S, Smania N, Cisari C, Santamato A, de Sire A, Invernizzi M.
    Ann Phys Rehabil Med; 2019 Jul 08; 62(4):214-219. PubMed ID: 31228593
    [Abstract] [Full Text] [Related]

  • 14. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.
    Chen YT, Zhang C, Liu Y, Magat E, Verduzco-Gutierrez M, Francisco GE, Zhou P, Zhang Y, Li S.
    Toxins (Basel); 2020 Jul 31; 12(8):. PubMed ID: 32751970
    [Abstract] [Full Text] [Related]

  • 15. The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait.
    Bleyenheuft C, Cockx S, Caty G, Stoquart G, Lejeune T, Detrembleur C.
    Gait Posture; 2009 Aug 31; 30(2):168-72. PubMed ID: 19442523
    [Abstract] [Full Text] [Related]

  • 16. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L, Valls-Solé J, Garcia Pascual I, Maisonobe P, on behalf of the VALGAS investigators group.
    Eur Neurol; 2019 Aug 31; 82(1-3):1-8. PubMed ID: 31726452
    [Abstract] [Full Text] [Related]

  • 17. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke.
    Veverka T, Hluštík P, Tomášová Z, Hok P, Otruba P, Král M, Tüdös Z, Zapletalová J, Herzig R, Krobot A, Kaňovský P.
    J Neurol Sci; 2012 Aug 15; 319(1-2):89-95. PubMed ID: 22687958
    [Abstract] [Full Text] [Related]

  • 18. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE, Knutzen A, Kühl C, Möller B, Hellriegel H, Margraf NG, Deuschl G, Stolze H.
    Brain Inj; 2017 Aug 15; 31(1):75-82. PubMed ID: 27880052
    [Abstract] [Full Text] [Related]

  • 19. Walking assessment with instrumented insoles in patients with lower limb spasticity after botulinum toxin infiltration.
    Béseler MR, Grao CM, Gil A, Martínez Lozano MD.
    Neurologia; 2012 Aug 15; 27(9):519-30. PubMed ID: 22088852
    [Abstract] [Full Text] [Related]

  • 20. Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation.
    Battaglia M, Cosenza L, Scotti L, Bertoni M, Polverelli M, Loro A, Santamato A, Baricich A.
    Toxins (Basel); 2021 Dec 12; 13(12):. PubMed ID: 34941726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.